DE2019778B2 - METHOD FOR DETERMINING THE INTRACELLULAR DISTRIBUTION OF RIBONUCLEIC ACIDS - Google Patents
METHOD FOR DETERMINING THE INTRACELLULAR DISTRIBUTION OF RIBONUCLEIC ACIDSInfo
- Publication number
- DE2019778B2 DE2019778B2 DE19702019778 DE2019778A DE2019778B2 DE 2019778 B2 DE2019778 B2 DE 2019778B2 DE 19702019778 DE19702019778 DE 19702019778 DE 2019778 A DE2019778 A DE 2019778A DE 2019778 B2 DE2019778 B2 DE 2019778B2
- Authority
- DE
- Germany
- Prior art keywords
- dye
- group
- staining
- alcoholic
- sections
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims description 17
- 229920002477 rna polymer Polymers 0.000 title claims description 8
- 230000003834 intracellular effect Effects 0.000 title claims description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- 238000010186 staining Methods 0.000 claims description 7
- 239000000975 dye Substances 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- KUUVQVSHGLHAKZ-UHFFFAOYSA-N thionine Chemical group C=1C=CC=CSC=CC=1 KUUVQVSHGLHAKZ-UHFFFAOYSA-N 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 4
- 229950003937 tolonium Drugs 0.000 claims description 4
- COQLPRJCUIATTQ-UHFFFAOYSA-N Uranyl acetate Chemical compound O.O.O=[U]=O.CC(O)=O.CC(O)=O COQLPRJCUIATTQ-UHFFFAOYSA-N 0.000 claims description 3
- 239000000981 basic dye Substances 0.000 claims description 3
- 230000003458 metachromatic effect Effects 0.000 claims description 3
- 230000001476 alcoholic effect Effects 0.000 claims description 2
- 230000002378 acidificating effect Effects 0.000 claims 2
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 230000001413 cellular effect Effects 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 238000006140 methanolysis reaction Methods 0.000 claims 1
- 230000011987 methylation Effects 0.000 claims 1
- 238000007069 methylation reaction Methods 0.000 claims 1
- 230000002085 persistent effect Effects 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- -1 uranyl ions Chemical class 0.000 claims 1
- 239000000243 solution Substances 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- REQPQFUJGGOFQL-UHFFFAOYSA-N dimethylcarbamothioyl n,n-dimethylcarbamodithioate Chemical compound CN(C)C(=S)SC(=S)N(C)C REQPQFUJGGOFQL-UHFFFAOYSA-N 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- KMUONIBRACKNSN-UHFFFAOYSA-N potassium dichromate Chemical compound [K+].[K+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O KMUONIBRACKNSN-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 241000256128 Chironomus <genus> Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910001981 cobalt nitrate Inorganic materials 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- INCIMLINXXICKS-UHFFFAOYSA-M pyronin Y Chemical compound [Cl-].C1=CC(=[N+](C)C)C=C2OC3=CC(N(C)C)=CC=C3C=C21 INCIMLINXXICKS-UHFFFAOYSA-M 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 125000005289 uranyl group Chemical group 0.000 description 1
- 229910002007 uranyl nitrate Inorganic materials 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
- G01N2001/305—Fixative compositions
- G01N2001/307—Fixative compositions non-toxic, no Hg, no formaldehyde
Description
Die vorliegende Erfindung betrifft ein Verfahren strukturen sich orthochromatisch, d. h. hellblau zur Bestimmung der intrazellulären Verteilung der 25 färben.The present invention relates to a method of structuring orthochromatically, i. H. Light Blue to determine the intracellular distribution of the 25 stain.
Ribonukleinsäuren durch Anfärben von vorher fixier- Zum Testen des erfindungsgemäßen VerfahrensRibonucleic acids by staining previously fixed For testing the method according to the invention
ten Schnitten tierischer und pflanzlicher Gewebe mit wurden Mäuse- und Rattenleber, Rattenhepatom, basischen Farbstoffen der Thioningruppe. Larven von Chironomus tetans und Drosophilla me-th sections of animal and plant tissue with were mouse and rat liver, rat hepatoma, basic dyes of the thionine group. Larvae of Chironomus tetans and Drosophilla me-
Die Kenntnis der Ribonukleinsäureverteilung in lanogaster und Wurzelspitzen verschiedener Pflanzenden Zellen ist von hervorragender Bedeutung für die 30 arten verwendet.Knowledge of the ribonucleic acid distribution in lanogaster and root tips of different plant ends Cells is of paramount importance to the 30 species used.
Zellbiologie. Zur Bestimmung der Ribonukleinsäure- Im folgenden wird das erfindungsgemäße Verfah-Cell biology. To determine the ribonucleic acid, the method according to the invention is described below
verteilung sind bereits zahlreiche Verfahren bekannt. ren an Hand eines Ausführungsbeispiels näher cr-Man kennt z.B. metachromatische Methoden, welche läutert:numerous processes are already known. ren using an exemplary embodiment in more detail cr-Man knows e.g. metachromatic methods, which purify:
auf der Eigenschaft des Toluidinblaus und des Kleine Teilchen von Tiergeweben (Volumen == 1 bison the property of toluidine blue and the small particles of animal tissues (volume == 1 to
Azurs I und II basieren, rotfarbige Verbindungen 35 2 mm3), Larven oder Wurzelspitzen (2 bis 3 mm lang)
mit der Ribonukleinsäure und den Fettstoffen zu werden 12 bis 24 Stunden bei 5 bis 80C mit einem
bilden (vgl. zum Beispiel B. Romeis, Mikrosko- der unten angegebenen Fixiermittel behandelt:
pische Technik, 16. Auflage, München 1968, S. 151,Azurs I and II are based on red-colored compounds 35 2 mm 3 ), larvae or root tips (2 to 3 mm long) with the ribonucleic acid and the fatty substances to be formed with a 12 to 24 hours at 5 to 8 0 C (cf. for example B. Romeis, Mikrosko- the fixing agent given below treats:
pische Technik, 16th edition, Munich 1968, p. 151,
152, 171, 172); diese Methoden sind jedoch unspezi- I· 0,5gewichtsprozentige Chromsäurefisch und unselektiv. Demselben Zweck dient das 40 lösung ° ml152, 171, 172); However, these methods are unspecific and unselective. The 40 ° ml solution serves the same purpose
Pyronin, das die ribonukleinischen Zellstrukturen rot Eisessig 0,4 mlPyronin, which the ribonuclein cell structures red glacial acetic acid 0.4 ml
färbt; mit dieser Methode erreicht man jedoch weder 4O°/oiges Formol 1,6 mlcolors; With this method, however, neither 40% strength formula 1.6 ml is obtained
den Nachweis der chromosomischen Ribonuklein- Jj- Kobaltnitrat 0,1gthe detection of the chromosomic ribonuclein Jj - cobalt nitrate 0.1g
säure, noch erhält man Auskunft über die Nukleol- Uranylnitrat 0,1 gacid, one still gets information about the nucleol uranyl nitrate 0.1 g
struktur. 45 50/oige Kaliumbichromatlösung 3 mlstructure. 45 50% potassium dichromate solution 3 ml
Weiterhin sind elektronenmikroskopische und auto- Äthanol 6 mlFurthermore, electron microscopic and auto-ethanol 6 ml
radiograpbische Methoden bekannt, bei welchen man Äthyläther 2 mlradiographic methods known, in which one ethyl ether 2 ml
tritiumhaltiges Uridin (H3) als Vorgänger in der Ri- 4O°/oiges Formol 4 mlTritiated uridine (H 3 ) as a predecessor in the R-40% formula 4 ml
bonukleinsäurebiosynthese benutzt; beide Verfahren Eisessig 1 mlused bonucleic acid biosynthesis; both methods glacial acetic acid 1 ml
setzen jedoch eine teure Apparatur voraus und sind 50however, require expensive equipment and are 50
schwierig durchzuführen. Das Fixiermittel wird unter Verwendung von ana-difficult to perform. The fixative is applied using ana-
Aufgabe der vorliegenden Erfindung ist es daher, lysenreinen Substanzen hergestellt,
die bekannten unspezifischen Anfärbeverfahren mit Nach Fixierung werden die Teile mit kaltem Was-The object of the present invention is therefore to produce lysis-pure substances,
the well-known unspecific staining process with After fixation, the parts are treated with cold water
Thioninfarbstoffen so zu verbessern, daß ein spezi- ser gewaschen, entwässert, in Paraffin eingelagert und fischer Nachweis der Ribonukleinsäuren ermöglicht 55 gemäß der üblichen Technik Schnitte von 3 bis 5 Miwird. krön hergestellt. Nach Entparaffinieren werden dieTo improve thionine dyes so that a specific is washed, dehydrated, stored in paraffin and The fischer detection of ribonucleic acids enables cuts of 3 to 5 milliliters according to the usual technique. crown made. After dewaxing, the
Diese Aufgabe wird erfindungsgemäß dadurch ge- Präparate in zwei Gruppen A und B geteilt,
löst, daß die Schnitte vor dem Anfärben zuerst mit Die Präparate der Gruppe A werden 20 MinutenAccording to the invention, this object is divided into two groups A and B,
solves that the sections before staining first with The preparations of group A are 20 minutes
0,8 Volumprozent konzentrierte Salzsäure enthalten- lang bei 60° C, in 0,1 N HCl-Lösung gebracht, gedem Methanol und dann mit 0,5- bis lgewichtspro- 60 waschen und entwässert.Contains 0.8 percent by volume of concentrated hydrochloric acid - long at 60 ° C, brought into 0.1 N HCl solution, gem Wash methanol and then with 0.5 to 1 weight percent and dehydrate.
zentiger wäßrig-alkoholischer Uranylacetatlösung vor- Sowohl die auf diese Weise behandelten Präparatecentiger aqueous-alcoholic uranyl acetate solution before- Both the preparations treated in this way
behandelt werden und anschließend die Färbung mit der Gruppe A, wie auch diejenigen der Gruppe B einer 0,005- bis 0,01gewichstprozentigen, wäßrig- werden derselben Behandlung unterworfen: Die alkoholischen gepufferten Lösung des Farbstoffs Präparate werden nacheinander in drei Bäder mit durchgeführt wird. 65 absolutem Methanol gebracht und anschließendare treated and then the staining with group A, as well as those of group B a 0.005 to 0.01 percent by weight, aqueous- are subjected to the same treatment: The alcoholic buffered solution of the dye preparations are used successively in three baths is carried out. 65 brought absolute methanol and then
Das Verfahren stützt sich auf die Eigenschaft der 1 Stunde bei 37° C in absolutem Methanol, welches basischen Farbstoffe aus der Thioningruppe und be- 0,8 ml konz. HCl (D = 1,19) pro 100 ml Alkohol sonders des O-Toluidinblaus, alle ribonukleinischen enthält, stehengelassen. Anschließend werden dieThe method relies on the property of 1 hour at 37 ° C in absolute methanol, which basic dyes from the thionine group and 0.8 ml conc. HCl (D = 1.19) per 100 ml of alcohol but the O-toluidine blue, which contains all ribonucleic substances, was left to stand. Then the
3 - 4 3 - 4
■ herausgenommen, wenigstens zehnmal mit■ taken out, at least ten times
erw^gekühltem destilliertem Wasser bei 5 bis 8° C ^™™^^ Unter3uchung der auf dieseexp ^ chilled distilled water at 5 to 8 ° C ^^ ^ ™™ sub 3uchung of this
gewaschen und nachher in eine 0,5- bis l< >/oige Essig- Die ™™^' zei^ daß aUe ribonuklei-washed and subsequently in a 0.5 to l <> / o acetic The ™™ ^ '^ zei that Aue ribonuklei-
uranyllösung in SOVoigem Methanol eingetragen und ^""^t gefärbt sind. So erscheinturanyl solution entered in SOVoigem methanol and ^ "" ^ t are colored. So appears
!Stunde bei Zimmertemperatur stehengelassen; 5 ^^*"J2KRibonlikleinsäure in Form vonLeft to stand for one hour at room temperature; 5 ^^ * "J2KRibonic acid in the form of
darauf werden die Schnitte wemgstens zehnmal mit ^.^^SSSi rotgefärbten Granulationen,then the sections are at least ten times with ^. ^^ SSSi red-colored granulations,
gekühltem Wasser bei 5 bis 8° C gewaschen und ^^^^^bon^Meinsäure ist gekenn-washed in chilled water at 5 to 8 ° C and ^^^^^ bon ^ myic acid is identified
fo Minuten bei Zimmertemperatur in einer Puffer- Οι^°^°^ε Gramiiationen, die längs derfo minutes at room temperature in a buffer Οι ^ ° ^ ° ^ ε grami iations running along the
lösung vom pH-Wert 3,4 bis 3,6 stehengelassen, die ^^^ten Chromosome angeordnet sind,solution of pH 3.4 to 3.6 left standing, the ^^^ th chromosomes are arranged,
wie folgt zusammengesetzt ist: ™ ^^^i^Mie aus den Riesenchromosomenis composed as follows: ™ ^^^ i ^ Mie from the giant chromosomes
12,5 ml der Speicheldrüsen voi12.5 ml of the salivary glands voi
8 ml haben die Form von8 ml are in the form of
4 ml schrägen Streifen anj4 ml inclined strips anj
45,5 ml45.5 ml
30 ml schieaener uroncu, ^ m — ——30 ml schieaener uroncu, ^ m - ——
(Der pH-Wert wird bei der Lösung ohne Methanol ^o^^ndSSmiß^erfahren kann vorteilhaft eingestellt.) mm Studium des Nukleclverhaltens während der(The pH is experienced in the solution without methanol ^ o ^^ ^ ndSSmiß can be adjusted advantageously.) Mm study of Nukleclverhaltens during the
Schließlich trägt man die Präparate direkt in die *o ^«gHf^VSS. Ä und frisch hergestellte Farbstofflösung ein, welche durch schtose ^ ^ ™ ^^ in den krebs-Auflösen von 0,005- bis 0,01 gewichtsprozentigem ^^^Prozessen geben und kann Aufschluß O-Toluidinblau (Merck) in obiger Pufferlosung her- ^|^η^°η^εί5ε der nukleol-organisierenden bestellt wurde, und läßt_45 bis 48 Stunden toZmi- ^ ^ä^STüber die Herkunft der Mikro-Finally, the preparations are carried directly into the * o ^ «gHf ^ VSS. Ä and freshly prepared dye solution, which through schtose ^ ^ ™ ^^ in the cancer s-dissolving 0.005 to 0.01 weight percent ^^^ processes and can digest O-toluidine blue (Merck) in the above buffer solution ^ η ^ ° η ^ εί5ε the nucleol-organizing was ordered, and lets_45 to 48 hours toZmi- ^ ^ ä ^ ST about the origin of the micro-
nukleole, Nukleoline und Karyosome geben.give nucleols, nucleolins and karyosomes.
Claims (2)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19702019778 DE2019778B2 (en) | 1970-04-23 | 1970-04-23 | METHOD FOR DETERMINING THE INTRACELLULAR DISTRIBUTION OF RIBONUCLEIC ACIDS |
FR7018020A FR2088100A1 (en) | 1970-04-23 | 1970-05-19 | Detmn of ribonucleic acid distribution in cells |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19702019778 DE2019778B2 (en) | 1970-04-23 | 1970-04-23 | METHOD FOR DETERMINING THE INTRACELLULAR DISTRIBUTION OF RIBONUCLEIC ACIDS |
Publications (2)
Publication Number | Publication Date |
---|---|
DE2019778A1 DE2019778A1 (en) | 1971-11-18 |
DE2019778B2 true DE2019778B2 (en) | 1973-02-08 |
Family
ID=5769045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19702019778 Granted DE2019778B2 (en) | 1970-04-23 | 1970-04-23 | METHOD FOR DETERMINING THE INTRACELLULAR DISTRIBUTION OF RIBONUCLEIC ACIDS |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE2019778B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0314293A2 (en) * | 1987-09-21 | 1989-05-03 | Cell Analysis Systems, Inc. | A kit and method for analyses of biological specimens |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4581223A (en) * | 1980-03-12 | 1986-04-08 | Lawrence Kass | Individual leukocyte determination by means of differential metachromatic dye sorption |
US5281517A (en) * | 1985-11-04 | 1994-01-25 | Cell Analysis Systems, Inc. | Methods for immunoploidy analysis |
US5134662A (en) * | 1985-11-04 | 1992-07-28 | Cell Analysis Systems, Inc. | Dual color camera microscope and methodology for cell staining and analysis |
US5202931A (en) * | 1987-10-06 | 1993-04-13 | Cell Analysis Systems, Inc. | Methods and apparatus for the quantitation of nuclear protein |
-
1970
- 1970-04-23 DE DE19702019778 patent/DE2019778B2/en active Granted
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0314293A2 (en) * | 1987-09-21 | 1989-05-03 | Cell Analysis Systems, Inc. | A kit and method for analyses of biological specimens |
EP0314293A3 (en) * | 1987-09-21 | 1990-05-09 | Cell Analysis Systems, Inc. | An apparatus and method for analyses of biological specimens |
Also Published As
Publication number | Publication date |
---|---|
DE2019778A1 (en) | 1971-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2954076C2 (en) | ||
DE2019778B2 (en) | METHOD FOR DETERMINING THE INTRACELLULAR DISTRIBUTION OF RIBONUCLEIC ACIDS | |
DE1045377C2 (en) | Process for stabilizing selenium disulphide which is suitable for the production of fungicides and which is activated by adding a hydrophilic colloidal suspending agent | |
DE1102973B (en) | Process for the production of highly purified kallikrein preparations | |
DE3231628C2 (en) | Electrophoresis gel | |
EP3394610B1 (en) | Method for the in-ovo sex identification of chicks | |
DE3231627C2 (en) | Polysaccharide-based electrophoresis gel and its application | |
DE2707913C2 (en) | Method for the detection of rheumatoid factors | |
DE753235C (en) | Process for the production of aqueous lactoflavin solutions | |
DE4212156A1 (en) | Aqueous textile treatment agent with low viscosity | |
DE469179C (en) | Process for the preparation of dye compounds soluble in organic solvents | |
Brown | A modified root tip smear technic | |
DE1299445B (en) | Glucose Diagnostic | |
DE2134519B2 (en) | Process for the diazotization of amines | |
DE673535C (en) | Process for the stabilization of cellulose esters of organic acids | |
DE930579C (en) | Separating the components of actinomycin C | |
Kraffczyk et al. | Die Dünnschicht-Chromatographie der Aminosäuren im Harn auf Zweischichtenplatten | |
CH273953A (en) | Process for the production of amines. | |
AT117985B (en) | Process for the production of oil solutions for therapeutically applicable substances. | |
DE589354C (en) | Process for staining hardened proteinoplasts | |
DE451784C (en) | Process for the manufacture of products which absorb ultraviolet light | |
DE577107C (en) | Process for the conversion of diacetyl monoxime into diacetyl | |
DE461303C (en) | Process for making ethyl alcohol gel | |
DE457579C (en) | Process for the preparation of Kuepen dyes | |
DE248886C (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C3 | Grant after two publication steps (3rd publication) |